国宏工具带“病”IPO遭倒查,申万宏源承销保荐被处分

Group 1 - The Shanghai Stock Exchange has issued four disciplinary actions against Guohong Tool System (Wuxi) Co., Ltd. and its related intermediaries due to multiple issues including inaccurate R&D data and improper disclosure of actual controllers [2][4] - Guohong Tool, established in 2004, primarily engages in specialized equipment manufacturing and applied for an IPO on the Sci-Tech Innovation Board in June 2023, with Shenwan Hongyuan Securities as the sponsor [5][6] - Shenwan Hongyuan Securities failed to adequately verify the accuracy of R&D personnel and investment amounts, leading to a miscalculation of R&D expenses by 7.2784 million yuan [5][6] Group 2 - The company did not follow proper decision-making procedures for a buyback obligation with its controlling shareholder, which was not disclosed in the shareholder meeting agenda [6][7] - Shenwan Hongyuan also failed to accurately identify the actual controllers' concerted actions, as there were undisclosed economic ties between the actual controller and his brothers [6][7] - The company had significant accounts receivable risks, with overdue amounts totaling 13.6395 million yuan out of a total of 18.0786 million yuan [7][8] Group 3 - The disciplinary actions include a one-year ban on Guohong Tool from submitting IPO applications and a six-month ban on two representatives from Shenwan Hongyuan from signing application documents [8][9] - Other parties involved, including the auditing firm and legal advisors, also faced penalties, with public reprimands issued to responsible individuals [8][9] - Shenwan Hongyuan has faced multiple regulatory warnings in 2024, with a 50% withdrawal rate of its sponsored projects, indicating ongoing compliance issues [10][11]